Evaluation of tumor M2-pyruvate kinase (Tumor M2-PK) as a biomarker for pancreatic cancer

Evaluation of tumor M2-pyruvate kinase (Tumor M2-PK) as a biomarker for pancreatic cancer

Abstract Background Expression of the dimeric M2 isoenzyme of pyruvate kinase, termed Tumor M2-PK, is increased in some human cancers. This study evaluates the potential role of pre-operative Tumor M2-PK as a marker of prognosis in patients with pancreatic malignancy. Methods Seventy-three consecuti...

Full description

Bibliographic Details
Main Authors: Indika A. Bandara, Minas Baltatzis, Sudip Sanyal, Ajith K. Siriwardena
Format: Article
Language:English
Published: BMC 2018-03-01
Series:World Journal of Surgical Oncology
Subjects:
Pancreatic cancer
Cancer prognosis
Tumor M2-PK
Online Access:http://link.springer.com/article/10.1186/s12957-018-1360-3

Internet

http://link.springer.com/article/10.1186/s12957-018-1360-3

Similar Items